Figure 4From: Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient miceA: Number of type II cells per lung. B: Mean volume of type II cells. Whereas only after 6 weeks of treatment a slight decrease in type II cell number was found the cellular volume was already reduced after 3 weeks. The reduction of cell number went on after 9 weeks of treatment.Back to article page